Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 2. Design, synthesis, and evaluation of a novel series of phenyl oxazole derivatives.

被引：6

作者：

Takeuchi, K ^{[1
]}

Kohn, TJ ^{[1
]}

Mais, DE ^{[1
]}

True, TA ^{[1
]}

Wyss, VL ^{[1
]}

Jakubowski, JA ^{[1
]}

机构：

[1] Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 15期

关键词：

D O I：

10.1016/S0960-894X(98)00353-9

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Synthesis and initial in vitro evaluation of a novel series of phenyl oxazole derivatives are described. An SAR study of the novel dual-acting TRA/TSI agent has revealed that the lipophilicity of the oxazole amide substituents greatly influences the TRA activity but not the TSI. The chain length of the alkenoic acid side chain affects both TRA and TSI. The optimal chain length for the combined activities was found to be n = 4 (heptenoic acid). (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

收藏

页码：1943 / 1948

页数：6

相关论文

共 29 条

[1] THROMBOXANE-A2 - ITS GENERATION AND ROLE IN PLATELET ACTIVATION [J].

ARITA, H ;

NAKANO, T ;

HANASAKI, K .

PROGRESS IN LIPID RESEARCH, 1989, 28 (04) :273-301

[2] THROMBOXANE RECEPTOR ANTAGONISM COMBINED WITH THROMBOXANE SYNTHASE INHIBITION .4. 8-[[(4-CHLOROPHENYL)SULFONYL]AMINO]-4-(3-(3-PYRIDINYL)PROPYL)OCTANOIC ACID AND ANALOGS [J].

BHAGWAT, SS ;

GUDE, C ;

BOSWELL, C ;

CONTARDO, N ;

COHEN, DS ;

DOTSON, R ;

MATHIS, J ;

LEE, W ;

FURNESS, P ;

ZOGANAS, H .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) :4373-4383

[3] SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF COMBINED THROMBOXANE RECEPTOR ANTAGONIST SYNTHASE INHIBITORS - PYRIDINE-CONTAINING SULFONAMIDO ACIDS [J].

CAMPBELL, IB ;

COLLINGTON, EW ;

FINCH, H ;

HAYES, R ;

LUMLEY, P ;

MILLS, K ;

PIKE, NB ;

ROBERTSON, GM ;

WATTS, IS .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (12) :699-704

[4]

COLLINGTON EW, 1990, ANNU REP MED CHEM, V25, P99

[5]

CROSS PE, 1991, CHEM BRIT, V27, P911

[6] NICKEL PEROXIDE DEHYDROGENATION OF OXYGEN-CONTAINING, SULFUR-CONTAINING, AND NITROGEN-CONTAINING HETEROCYCLES [J].

EVANS, DL ;

MINSTER, DK ;

JORDIS, U ;

HECHT, SM ;

MAZZU, AL ;

MEYERS, AI .

JOURNAL OF ORGANIC CHEMISTRY, 1979, 44 (04) :497-501

[7] DUAL-ACTING THROMBOXANE RECEPTOR ANTAGONIST SYNTHASE INHIBITORS - HETEROCYCLIC VARIATIONS [J].

FAULL, AW ;

GASKIN, H ;

HADFIELD, PS ;

JESSUP, R ;

RUSSELL, K ;

WATKINS, WJ ;

WAYNE, M .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (10) :1181-1186

[8] THROMBOXANE SYNTHASE INHIBITORS, THROMBOXANE RECEPTOR ANTAGONISTS AND DUAL BLOCKERS IN THROMBOTIC DISORDERS [J].

GRESELE, P ;

DECKMYN, H ;

NENCI, GG ;

VERMYLEN, J .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (04) :158-163

[9] THROMBOXANE A2 RECEPTOR ANTAGONISTS [J].

HALL, SE .

MEDICINAL RESEARCH REVIEWS, 1991, 11 (05) :503-579

[10]

HALUSHKA PV, 1989, DRUG TODAY, V26, P383